Clinical Trials in San Francisco

Showing 1541-1560 of 11,161 trials

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

NCT07335601

A Phase 2 double-blind, randomized, placebo-controlled study to evaluate resmetirom in 2 cohorts of subjects with moderate to advanced fibrosis, consistent with stage F2 and F3 fibrosis, who have undergone liver transplant. Cohort 1 will consist of patients who have undergone liver transplant for MASH cirrhosis who developed recurrent MASH. Cohort 2 will consist of subjects who have undergone liver transplant for indications other than MASH cirrhosis who developed de novo MASH.

MASH - Metabolic Dysfunction-Associated Steatohepatitis

Madrigal Pharmaceuticals, Inc.120 participantsStarted Dec 2025

La Jolla, California, United States • Los Angeles, California, United States • San Francisco, California, United States +12 more locations

Active Not Recruiting< 1 mile

Liver Cirrhosis Network Cohort Study

NCT05740358

Liver Cirrhosis Network (LCN) Cohort Study is an observational study designed to identify risk factors and develop prediction models for risk of decompensation in adults with liver cirrhosis. LCN Cohort Study involves multiple institutions and an anticipated 1200 participants. Enrolled participants will have study visits every 6 months (180 days), with opportunities to complete specific visit components via telehealth or remotely. Visits will include collection of questionnaire data and the in-person visits will include questionnaires, physical exams, imaging, and sample collection.

CirrhosisCirrhosis, LiverCirrhosis Early+9 more

Northwestern University1,222 participantsStarted Nov 2022

La Jolla, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +11 more locations

Study to Evaluate Resmetirom in Post-Liver Transplant Patients With MASH

Liver Cirrhosis Network Cohort Study

Find Trials by Condition in San Francisco

Multi-Institutional Transgender & Gender-Diverse Breast Cancer Study

Hyperpolarized Carbon-13 Alpha-ketoglutarate Imaging in IDH Mutant Glioma

A Study to Learn About the Long-Term Health of Adult Participants From a Previous Study of a New Melanoma Treatment

Identifying Best Approach in Improving Quality of Life and Survival After a Donor Stem Cell Transplant in Older, Medically Infirm, or Frail Patients With Blood Diseases

RNS System LGS Feasibility Study

Gemcitabine Hydrochloride and Cisplatin With or Without Nab-Paclitaxel in Treating Patients With Newly Diagnosed Advanced Biliary Tract Cancers

Randomized Withdrawal Study in Patients With Schizophrenia

Efficacy and Safety of Aspirin and Lansoprazole for Prevention of Preterm Birth in High-Risk Pregnant Women: A Biomarker-Enriched Trial

Trial of Center-Based vs. In-Home Pivotal Response Treatment (PRT) in Autism

FORAGER-1: A Study of LOXO-435 (LY3866288) in Participants With Cancer With a Change in a Gene Called FGFR3

A Study of Adjuvant Cretostimogene Grenadenorepvec for Treatment of Intermediate Risk NMIBC Following TURBT

Study of ENV-294 in Healthy Adults and in Adults With Moderate-to-Severe Atopic Dermatitis

Algorithm Using LINQ Sensors for Evaluation And Treatment of Heart Failure

A Study of Brepocitinib in Adults With Active, Non-Infectious, Non-Anterior Uveitis

Study of Onvansertib in Combination With FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab Versus FOLFIRI and Bevacizumab or FOLFOX and Bevacizumab for First-Line Treatment of Metastatic Colorectal Cancer in Adult Participants With a KRAS or NRAS Mutation

Anticoagulation for Stroke Prevention In Patients With Recent Episodes of Atrial Fibrillation Occurring Transiently With Stress

A Phase 1 Study of UB-VV111 With and Without Rapamycin in Relapsed/Refractory CD19+ B-cell Malignancies

A Trial to Learn if the Combination of Fianlimab, Cemiplimab, and Chemotherapy is Safe and Works Better Than the Combination of Cemiplimab and Chemotherapy in Adult Patients With Non-Small Cell Lung Cancer That Can be Treated With Surgery